白血病是一种罕见但致命的血液癌症。这种癌症是由异常的骨髓细胞引起的,需要及时诊断以进行有效的治疗和积极的患者预后。传统的诊断方法(例如,显微镜,流式细胞术,和活检)在准确性和时间上都面临挑战,要求对深度学习(DL)模型的开发和使用进行探究,如卷积神经网络(CNN),这可以提供更快,更准确的诊断。使用特定的,客观标准,DL可能有望成为医生诊断白血病的工具。这篇综述的目的是报告有关使用DL诊断白血病的相关已发表文献。使用系统审查和荟萃分析(PRISMA)指南的首选报告项目,使用Embase搜索了2010年至2023年发表的文章,OvidMEDLINE,和WebofScience,搜索术语“白血病”和“深度学习”或“人工神经网络”或“神经网络”和“诊断”或“检测”。“在使用预先确定的资格标准筛选检索到的文章后,由于该现象的新生性质,最终审查中包括了20篇文章,并按时间顺序进行了报告。最初的研究为随后的创新奠定了基础,说明了利用DL技术进行白血病检测从专门方法到更通用方法的过渡。对最近DL模型的总结揭示了向集成架构的范式转变,显著提高了准确性和效率。模型和技术的不断完善,再加上强调简单和效率,将DL定位为白血病检测的有前途的工具。在这些神经网络的帮助下,白血病检测可以加快,改善长期前景和预后。需要使用现实生活中的情景进行进一步的研究,以确认DL模型可能对白血病诊断产生的变革性影响。
Leukemia is a rare but fatal cancer of the blood. This cancer arises from abnormal bone marrow cells and requires prompt diagnosis for effective treatment and positive patient prognosis. Traditional diagnostic methods (e.g., microscopy, flow cytometry, and biopsy) pose challenges in both accuracy and time, demanding an inquisition on the development and use of deep learning (DL) models, such as convolutional neural networks (CNN), which could allow for a faster and more exact diagnosis. Using specific, objective criteria, DL might hold promise as a tool for physicians to diagnose leukemia. The purpose of this
review was to report the relevant available published literature on using DL to diagnose leukemia. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, articles published between 2010 and 2023 were searched using Embase, Ovid MEDLINE, and Web of Science, searching the terms \"leukemia\" AND \"deep learning\" or \"artificial neural network\" OR \"neural network\" AND \"diagnosis\" OR \"
detection.\" After screening retrieved articles using pre-determined eligibility criteria, 20 articles were included in the final
review and reported chronologically due to the nascent nature of the phenomenon. The initial studies laid the groundwork for subsequent innovations, illustrating the transition from specialized methods to more generalized approaches capitalizing on DL technologies for leukemia
detection. This summary of recent DL models revealed a paradigm shift toward integrated architectures, resulting in notable enhancements in accuracy and efficiency. The continuous refinement of models and techniques, coupled with an emphasis on simplicity and efficiency, positions DL as a promising tool for leukemia detection. With the help of these neural networks, leukemia
detection could be hastened, allowing for an improved long-term outlook and prognosis. Further research is warranted using real-life scenarios to confirm the suggested transformative effects DL models could have on leukemia diagnosis.